Literature DB >> 6219114

"Activated" monocytes in gastric cancer patients. II. Suppressor and cytostatic activity in vitro.

W Uracz, B Mytar, M Zembala, I Ruggiero, T Popiela, A Czupryna.   

Abstract

The spontaneous nitro-blue tetrazolium (NBT) reduction of monocytes from patients with gastric cancer was assessed and compared with an in vitro monocyte-mediated cytostasis of tumor cell lines and their suppressor activity. The increased NBT reduction correlated with the ability of monocytes to inhibit mitogen-induced normal lymphocyte response and cytostatic activity against L-1210 murine lymphoma cell line. These observations suggest that "activated" monocytes of some cancer patients may play the role of suppressor cells and exert an anti-tumor effect in vitro.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6219114     DOI: 10.1007/bf00406249

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  18 in total

1.  Cytolytic and cytostatic activity on tumor cells of circulating human monocytes.

Authors:  A Mantovani; T R Jerrells; J H Dean; R B Herberman
Journal:  Int J Cancer       Date:  1979-01-15       Impact factor: 7.396

2.  Comparison of antiviral and antitumor activity of activated macrophages.

Authors:  P S Morahan; L A Glasgow; J L Crane; E R Kern
Journal:  Cell Immunol       Date:  1977-02       Impact factor: 4.868

Review 3.  Activation of mononuclear phagocytes: fact, fancy, and future.

Authors:  Z A Cohn
Journal:  J Immunol       Date:  1978-09       Impact factor: 5.422

4.  In vitro activation of a human macrophage-like cell line.

Authors:  H S Koren; S J Anderson; J W Larrick
Journal:  Nature       Date:  1979-05-24       Impact factor: 49.962

5.  Depressed in vitro peripheral blood lymphocyte response to mitogens in cancer patients: the role of suppressor cells.

Authors:  M Zembala; B Mytar; T Popiela; G L Asherson
Journal:  Int J Cancer       Date:  1977-05-15       Impact factor: 7.396

6.  Characterization of a human macrophage-like cell line stimulated in vitro: a model of macrophage functions.

Authors:  J W Larrick; D G Fischer; S J Anderson; H S Koren
Journal:  J Immunol       Date:  1980-07       Impact factor: 5.422

7.  Inhibition of proliferation of lymphoma cells and T lymphocytes by suppressor cells from spleens of tumor-bearing mice.

Authors:  H Kirchner; A V Muchmore; T M Chused; H T Holden; R B Herberman
Journal:  J Immunol       Date:  1975-01       Impact factor: 5.422

8.  Increased monocyte-mediated cytostasis of lymphoid cell lines in breast and lung cancer patients.

Authors:  T R Jerrells; J H Dean; G Richardson; G B Cannon; R B Herberman
Journal:  Int J Cancer       Date:  1979-06-15       Impact factor: 7.396

9.  "Activated" monocytes in gastric cancer patients. I. Increased Fc receptor expression, antibody-dependent cellular cytotoxicity and NBT reduction.

Authors:  W Uracz; A Pituch-Noworolska; M Zembala; T Popiela; A Czupryna
Journal:  J Cancer Res Clin Oncol       Date:  1982       Impact factor: 4.553

10.  Alterations of macrophage functions by mediators from lymphocytes.

Authors:  C F Nathan; M L Karnovsky; J R David
Journal:  J Exp Med       Date:  1971-06-01       Impact factor: 14.307

View more
  3 in total

1.  The role of shed Fc receptor in the regulation of lymphocyte response to phytohaemagglutinin (PHA).

Authors:  A Pituch-Noworolska; J Noworolski; J Pryjma; M Zembala
Journal:  Immunology       Date:  1985-08       Impact factor: 7.397

2.  Serial immunological testing in patients with gastric cancer.

Authors:  M Zembala; T Popiela; D Kowalczyk; B Mytar; A Pituch-Noworolska; I Ruggiero; W Uracz; A Czupryna; H Labza
Journal:  J Cancer Res Clin Oncol       Date:  1986       Impact factor: 4.553

3.  The altered expression of MHC-class II determinants on monocytes of cancer patients.

Authors:  W Uracz; J Stachura; A Pituch-Noworolska; T Popiela; A Czupryna; M Zembala
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.